Healthstream (HSTM) FY2020 results: revenue $245 million, down 3.7% on the year
Healthstream Inc. (HSTM) reported revenue of $245 million for fiscal 2020, the year ended 31 December 2020, down 3.7% on the year before. Net income was $14 million, down 10.6%, and diluted earnings per share $0.44. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2021.
Revenue
$245 million
-3.7% on the year
FY2013FY2020
Operating margin
6.5%
5.8% a year earlier
FY2013FY2020
Net income
$14 million
-10.6% on the year
FY2013FY2020
Diluted EPS
$0.44
-10.2% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
245
254
232
-3.7%
Cost of revenue
89.3
104
96.0
-14.0%
Gross profit
155
150
136
+3.5%
Gross margin
63.5%
59.1%
58.5%
Research and development
32.3
29.1
25.7
+11.0%
Operating income
15.8
14.7
15.5
+7.5%
Operating margin
6.5%
5.8%
6.7%
Pre-tax income
17.8
17.9
16.6
-0.6%
Income tax
3.7
3.7
3.3
-0.0%
Effective tax rate
20.9%
20.8%
20.1%
Net income
14.1
15.8
32.2
-10.6%
Net margin
5.8%
6.2%
13.9%
Diluted EPS
$0.44
$0.49
$1.00
-10.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
35.9
65.7
43.2
-45.4%
Capital expenditure
2.0
22.0
7.2
-91.0%
Free cash flow
33.9
43.7
36.1
-22.4%
Free cash flow margin
13.8%
17.2%
15.6%
Cash from investing
-110
-67.5
36.6
Cash from financing
-20.5
-0.9
-30.3
Depreciation and amortisation
30.2
27.9
24.2
+8.3%
Share-based compensation
2.2
4.2
1.8
-47.8%
Buybacks
20.0
0.0
n/a
Dividends paid
0.0
0.1
32.4
-31.0%
Dividend per share
n/a
n/a
$1.00
Diluted shares, weighted
32m
32m
32m
-1.4%
Shares outstanding at period end
31m
32m
32m
-2.7%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
334
338
319
-1.2%
Debt
0.0
0.0
0.0
Operating lease liabilities
28.5
30.7
n/a
-7.3%
Other liabilities
138
121
123
+14.2%
Total liabilities and equity
500
490
442
+2.2%
Fixed assets
22.2
26.1
15.9
-14.8%
Goodwill
178
102
86.1
+74.6%
Intangible assets
101
60.1
59.4
+67.6%
Investments
9.9
41.3
34.5
-76.0%
Cash and equivalents
36.6
132
134
-72.2%
Receivables
40.7
27.6
38.1
+47.3%
Other assets
112
101
73.6
+11.0%
Total assets
500
490
442
+2.2%
10-K for the year ended 31 December 2020, filed 26 February 2021: the filing.